TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $89 | +147.2% | 207 | +1.5% | 0.00% | – |
| Q4 2023 | $36 | +16.1% | 204 | +15.9% | 0.00% | – |
| Q3 2023 | $31 | -34.0% | 176 | +8.0% | 0.00% | – |
| Q2 2023 | $47 | -88.9% | 163 | -27.2% | 0.00% | – |
| Q1 2023 | $423 | +31.0% | 224 | +3.2% | 0.00% | – |
| Q4 2022 | $323 | -67.7% | 217 | -76.2% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 910 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 910 | +1.6% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 896 | -32.6% | 0.00% | – |
| Q4 2021 | $3,000 | -40.0% | 1,330 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | -91.2% | 1,330 | -84.8% | 0.00% | – |
| Q2 2021 | $57,000 | +35.7% | 8,759 | +74.4% | 0.00% | – |
| Q1 2021 | $42,000 | -51.2% | 5,022 | -31.5% | 0.00% | – |
| Q4 2020 | $86,000 | +514.3% | 7,329 | +166.1% | 0.00% | – |
| Q3 2020 | $14,000 | +366.7% | 2,754 | +53.2% | 0.00% | – |
| Q2 2020 | $3,000 | -82.4% | 1,798 | -82.1% | 0.00% | – |
| Q1 2020 | $17,000 | +183.3% | 10,062 | +275.9% | 0.00% | – |
| Q4 2019 | $6,000 | – | 2,677 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,013,438 | $10,409,000 | 2.04% |
| Ikarian Capital, LLC | 2,162,549 | $11,180,000 | 0.81% |
| Telemetry Investments, L.L.C. | 54,723 | $283,000 | 0.62% |
| Vigilare Wealth Management | 17,000 | $88,000 | 0.09% |
| Johnson & Johnson Innovation - JJDC, Inc. | 84,003 | $434,000 | 0.09% |
| NEA Management Company, LLC | 346,718 | $1,793,000 | 0.08% |
| BOOTHBAY FUND MANAGEMENT, LLC | 236,301 | $1,222,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 81,675 | $422,000 | 0.07% |
| Virtu Financial LLC | 61,180 | $316,000 | 0.05% |
| 683 Capital Management, LLC | 75,000 | $388,000 | 0.03% |